Delivery Order SPE2DB22D3401-SPE2DB25FT3FM

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,760,196 units of Methylphenidate ER 18 mg tablets in 100-count packages, with a total ceiling value of $1,209.06. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,859.93 firm fixed-price contract is for the supply of 4,568,143,834 units of the medication Methylphenidate ER 18 mg tablets. The contract has a performance period through May 6, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,467.56 firm-fixed-price contract is for the supply of 4,565,697,841 units of Methylphenidate ER 36 mg tablets, to be delivered by September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,563.04 firm-fixed-price contract is for the delivery of 4,566,322,636 units of the prescription drug Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,244,766 units of Methylphenidate ER 18 mg tablets. The $4,659.60 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,632.80, is for the procurement of 4,566,307,599 units of Methylphenidate ER 18 mg tablets. The award is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,881,105 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,316.99 award has a completion date of March 7, 2024 and does not utilize any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,731,300 units of Methylphenidate ER 18 mg tablets. The contract, valued at $1,894.65, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to the agency. This award is...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3FM
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,684.94, is for the supply of 4,567,957,738 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of April 18, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:35 PM